510(k) K230104

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL by Anthogyr — Product Code DZE

K230104 is an FDA 510(k) premarket notification submitted by Anthogyr for the device "Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL". The FDA issued a decision of Substantially Equivalent on October 16, 2023. The device falls under product code DZE (Implant, Endosseous, Root-Form), a Class II device regulated under 21 CFR 872.3640. Anthogyr has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 16, 2023
Date Received
January 13, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Implant, Endosseous, Root-Form
Device Class
Class II
Regulation Number
872.3640
Review Panel
DE
Submission Type